40 min
FendX Technologies (FNDX.CN/FDXTF) - Capital Market Series w/ Carolyn Myers, President & CEO NewGen Mindset
-
- Business
Capital Market Series - 007 with FENDX Technologies
In the seventh episode of NewGen Mindset's "Capital Market Series," Nic & Dan sit down with Carolyn Myers from FendX Technologies. With her, we dive into the proactive innovation of FendX using nanotechnologies to more optimally reduce the spread of pathogens through different patented product forms. The medical and health industry is plagued with reactive and old methods that is screaming for new innovation solutions, and FendX seeks to be at the forefront of that need.
Carolyn Meyers, MBA, PHD - President, Chief Executive Officer & Director
Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading healthcare businesses. She is also a Principal of BioEnsemble LLC, where she works closely with numerous start-ups and small pharma companies to assist them in developing their business strategy and planning. Her previous executive positions include Vice President International Business Development and Alliance Management at Allergan PLC, President of Dey Laboratories and President of Mylan Technologies Inc. Prior to serving in these roles, Dr. Myers served in various management positions in sales and marketing at Pharmacia Corporation., now a part of Pfizer, Inc. Dr. Myers is also a director at Mayne Pharma Group Ltd. and Hyloris Pharmaceuticals SA, both publicly listed companies. She earned her PhD in genetics from the University of British Columbia and her MBA from Rutgers University.
FendX Technologies is a Canada-based nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has an exclusive worldwide license to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.
The Company has a growing intellectual property portfolio consisting of licensed nonprovisional national stage patent applications which have been made in Canada, the United States, Europe, China, Hong Kong and Japan, as well as two licensed PCT applications.
Website: https://fendxtech.com/
https://www.newgenmindset.com/
Instagram: @newgenmindsetpod
X: @newgen_mindset
Disclaimer:
None of the information provided in this episode should be considered investment advice and should only be viewed for informational purposes. NewGenMindset is not a broker or a licensed provider of financial services. Any claims made in this episode to any listener should not be regarded as offering personalized legal or investment counseling. Any investments made in any companies should be consulted with a licensed financial professional from here on.
#nano #nanoscience #prevention #science #scienceandtechnology #nanoparticle #nanotechnology #FENDX #healthcare #cleaning #clean #cleansurface #usa #canada #quebec #pharmaceutical #economy #capitalmarkets #stocks #investing #stockmarket #windex #stockstowatch #stockstobuy #money #investing #smallcapstocks #smallcap #smallcapstock
---
Send in a voice message: https://podcasters.spotify.com/pod/show/newgenmindset/message
Capital Market Series - 007 with FENDX Technologies
In the seventh episode of NewGen Mindset's "Capital Market Series," Nic & Dan sit down with Carolyn Myers from FendX Technologies. With her, we dive into the proactive innovation of FendX using nanotechnologies to more optimally reduce the spread of pathogens through different patented product forms. The medical and health industry is plagued with reactive and old methods that is screaming for new innovation solutions, and FendX seeks to be at the forefront of that need.
Carolyn Meyers, MBA, PHD - President, Chief Executive Officer & Director
Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading healthcare businesses. She is also a Principal of BioEnsemble LLC, where she works closely with numerous start-ups and small pharma companies to assist them in developing their business strategy and planning. Her previous executive positions include Vice President International Business Development and Alliance Management at Allergan PLC, President of Dey Laboratories and President of Mylan Technologies Inc. Prior to serving in these roles, Dr. Myers served in various management positions in sales and marketing at Pharmacia Corporation., now a part of Pfizer, Inc. Dr. Myers is also a director at Mayne Pharma Group Ltd. and Hyloris Pharmaceuticals SA, both publicly listed companies. She earned her PhD in genetics from the University of British Columbia and her MBA from Rutgers University.
FendX Technologies is a Canada-based nanotechnology company focused on developing products to make people’s lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has an exclusive worldwide license to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.
The Company has a growing intellectual property portfolio consisting of licensed nonprovisional national stage patent applications which have been made in Canada, the United States, Europe, China, Hong Kong and Japan, as well as two licensed PCT applications.
Website: https://fendxtech.com/
https://www.newgenmindset.com/
Instagram: @newgenmindsetpod
X: @newgen_mindset
Disclaimer:
None of the information provided in this episode should be considered investment advice and should only be viewed for informational purposes. NewGenMindset is not a broker or a licensed provider of financial services. Any claims made in this episode to any listener should not be regarded as offering personalized legal or investment counseling. Any investments made in any companies should be consulted with a licensed financial professional from here on.
#nano #nanoscience #prevention #science #scienceandtechnology #nanoparticle #nanotechnology #FENDX #healthcare #cleaning #clean #cleansurface #usa #canada #quebec #pharmaceutical #economy #capitalmarkets #stocks #investing #stockmarket #windex #stockstowatch #stockstobuy #money #investing #smallcapstocks #smallcap #smallcapstock
---
Send in a voice message: https://podcasters.spotify.com/pod/show/newgenmindset/message
40 min
Top Podcasts In Business